or Try an Advanced Search...

    Technical Analysis for VIGL - Vigil Neuroscience, Inc.

    Grade Last Price % Change Price Change
    D 3.63 1.11% 0.04
    VIGL closed up 1.11 percent on Friday, May 24, 2024, on 58 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical VIGL trend table...
    Date Alert Name Type % Chg
    Stochastic Reached Overbought Strength 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Wide Bands Range Expansion 1.11%
    Wide Bands Range Expansion -1.36%
    Inside Day Range Contraction 3.71%
    Wide Bands Range Expansion 3.71%
    Wide Bands Range Expansion 4.01%
    Wide Bands Range Expansion 3.13%
    Older End-of-Day Signals for VIGL ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support 3 days ago
    60 Minute Opening Range Breakout 3 days ago
    Up 3% 3 days ago
    Up 2% 3 days ago
    Up 1% 4 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    VIGL Chart by TradingView
    Basic chart:

    Profile

    Vigil Neuroscience, Inc., a biotechnology company, discovers and develops novel therapeutics that take advantage of breakthroughs in science and human genetics of microglia. It harnesses the power of microglia for the treatment of neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. The company was incorporated in 2020 and is based in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Neurodegenerative Diseases Treatment Of Neurodegenerative Diseases Human Physiology

    Is VIGL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 17 Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
    Mar 24 Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?
    Mar 20 Vigil Neuroscience appoints Kaufmann as Chief Medical Officer
    Mar 20 Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
    Mar 12 Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days
    Mar 6 Vigil Announces Oral Presentation on Small Molecule TREM2 Agonist VG-3927 as a Potential Disease-Modifying Therapeutic at AD/PD 2024
    Feb 29 Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024
    Jan 4 Vigil Neuroscience remains on track to report interim Phase 1 data for VG-3927 in healthy volunteers in mid-2024
    Jan 3 Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones
    See more VIGL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.11
    52 Week Low 2.5
    Average Volume 99,975
    200-Day Moving Average 4.28
    50-Day Moving Average 3.16
    20-Day Moving Average 3.29
    10-Day Moving Average 3.57
    Average True Range 0.29
    RSI (14) 58.68
    ADX 26.55
    +DI 22.43
    -DI 11.61
    Chandelier Exit (Long, 3 ATRs) 2.97
    Chandelier Exit (Short, 3 ATRs) 3.38
    Upper Bollinger Bands 4.06
    Lower Bollinger Band 2.51
    Percent B (%b) 0.72
    BandWidth 47.17
    MACD Line 0.16
    MACD Signal Line 0.13
    MACD Histogram 0.0306
    Fundamentals Value
    Market Cap 130.23 Million
    Num Shares 35.9 Million
    EPS -2.02
    Price-to-Earnings (P/E) Ratio -1.80
    Price-to-Sales 0.00
    Price-to-Book 0.75
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.89
    Resistance 3 (R3) 3.89 3.81 3.84
    Resistance 2 (R2) 3.81 3.75 3.81 3.83
    Resistance 1 (R1) 3.72 3.70 3.77 3.72 3.81
    Pivot Point 3.64 3.64 3.66 3.64 3.64
    Support 1 (S1) 3.55 3.58 3.60 3.55 3.45
    Support 2 (S2) 3.47 3.53 3.47 3.43
    Support 3 (S3) 3.38 3.47 3.42
    Support 4 (S4) 3.38